Results 151 to 160 of about 704,631 (338)

INCREASED UNSATURATED TRANSCOBALAMIN II IN AUTOIMMUNE DISEASE; INFLUENCE OF IMMUNOSUPPRESSIVE THERAPY [PDF]

, 1978
Marijke Fràter‐Schröder, W. H. Hitzig, A B Kenny   +2 more
openalex   +1 more source

Glucocorticoids Alter Bone Microvascular Barrier via MAPK/Connexin43 Mechanisms

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Osteoporosis induced by Glucocorticoids (GCs) is a common complication of long‐term GC use in patients with inflammatory and autoimmune conditions, often leading to an increased fracture risk. A 3D bicellular endo‐osteo microfluidic platform is developed to explore pathogenic mechanisms underlying GCs‐induced osteoporosis, highlighting a novel MAPK ...
Eun‐Jin Lee, Peter Lialios, Micaila Curtis, James Williams IV, Yoontae Kim, Paul Salipante, Steven Hudson, Mandy B. Esch, Moshe Levi, Joanna Kitlinska, Stella Alimperti   +10 more
wiley   +1 more source

(2) Autoimmune Diseases of the Hematopoietic System with Special Reference to Autoimmunity to Red Blood Cells

, 1968
M Fukase
openalex   +2 more sources

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

Advanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang, Mengyuan Qian, Yirui Shi, Jiaxu Cao, Min Xu, Xin Wen, Yunxia Yan, Sha Liu, Hongwei Chen, Shanshan Liu, Jun Yang, Lingyun Sun   +11 more
wiley   +1 more source

From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis

Rheumatology and Therapy
Introduction Biologic therapies are licensed for both psoriasis (PsO) and psoriatic arthritis (PsA) with some electronic medical record data suggest that IL (Interleukin)-23 blockers might be more protective in PsA prevention than TNF blockers; however ...
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital   +8 more
doaj   +1 more source

(2) AUTOIMMUNE DISEASES OF THE HEMATOPOIETIC SYSTEM WITH SPECIAL REFERENCE TO AUTOIMMUNITY TO RED BLOOD CELLS

, 1967
M Fukase
openalex   +2 more sources

Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin's disease [PDF]

, 1982
Magnus Björkholm, Göran Holm, K. Merk
openalex   +1 more source

Immunomodulation With Local, Sustained Delivery of Pituitary Adenylate Cyclase Activating Polypeptide Results in Improved Functional Recovery in Stroke‐Injured Mice

Advanced Healthcare Materials, EarlyView.
The tissue and functional benefits are demonstrated with local, sustained delivery of an anti‐inflammatory peptide, pituitary adenylate cyclase‐activating polypeptide (PACAP), for stroke treatment in a mouse model. Prolonged PACAP treatment modulated astrocyte and microglia toward pro‐reparative phenotypes, enhanced neuroprotection and preservation of ...
Eric Ho, David Xinzheyang Li, Hong Cui, Dania Akbar, Ricky Siu, Cindi M. Morshead, David Chatenet, Molly S. Shoichet   +7 more
wiley   +1 more source

(1) THE AUTOIMMUNE DISEASE FROM THE VIEWPOINT OF GERMFREE ANIMAL RESEARCH

, 1967
Masasumi Miyakawa
openalex   +2 more sources

Sensorimotor Perineuritis – An Autoimmune Disease? [PDF]

, 1985
Christopher N. Bourque, Brian A. Anderson, C. Martin del Campo, Anders A. F. Sima   +3 more
openalex   +1 more source